Top

Published in:

01-02-2013 | Letter to the Editors

Deep magnetic stimulation in a progressive supranuclear palsy patient with speech involvement

Authors: Francesca Spagnolo, Elisabetta Coppi, Pasquale Anthony Della Rosa, Mario Fichera, Alessandra Barbieri, Giuseppe Magnani, Monica Falautano, Abraham Zangen, Giancarlo Comi, Daniela Perani, Maria Antonietta Volontè, Letizia Leocani

Published in: Journal of Neurology | Issue 2/2013

Excerpt

Dear Sir, …

Available only for authorised users

Gorno-Tempini ML, Dronkers NF, Rankin KP et al (2004) Cognition and anatomy in three variants of primary progressive aphasia. Ann Neurol 55:335–346PubMedCrossRef

Greene JD, Patterson K, Xuereb J et al (1996) Alzheimer disease and nonfluent progressive aphasia. Arch Neurol 53:1072–1078PubMedCrossRef

Wakabayashi K, Shibasaki Y, Hasegawa M et al (2000) Primary progressive aphasia with focal taupathy. Neuropathol Appl Neurobiol 26:477–480PubMedCrossRef

Josephs KA, Duffy JR, Strand EA et al (2006) Clinicopathological and imaging correlated of progressive aphasia and apraxia of speech. Brain 129:1385–1398PubMedCrossRef

Pell GS, Roth Y, Zangen A (2011) Modulation of cortical excitability induced by repetitive transcranial magnetic stimulation: influence of timing and geometrical parameters and underlying mechanisms. Prog Neurobiol 93:59–98PubMedCrossRef

Guse B, Falkai P, Wobrock T (2010) Cognitive effects of high-frequency repetitive transcranial magnetic stimulation: a systematic review. J Neural Transm 117:105–122PubMedCrossRef

Cotelli M, Manenti R, Alberici A et al (2012) Prefrontal cortex rTMS enhances action naming in progressive non-fluent aphasia. Eur J Neurol. doi:10.1111/j.1468-1331.2012.03699.x (Epub ahead of print)PubMed

Lefaucheur JP (2006) Repetitive transcranial magnetic stimulation (rTMS): insights into the treatment of Parkinson’s disease by cortical stimulation. Neurophysiol Clin 36(3):125–133PubMedCrossRef

Zangen A, Roth Y, Voller B, Hallett M (2005) Transcranial magnetic stimulation of deep brain regions: evidence for efficacy of the H-coil. Clin Neurophysiol 116:775–779PubMedCrossRef

10.

Roth Y, Amir A, Levkovitz Y, Zangen A (2007) Three-dimensional distribution of the electric field induced in the brain by transcranial magnetic stimulation using figure-8 and deep H-coils. J Clin Neurophysiol 24:31–38PubMedCrossRef

11.

Levkovitz Y, Roth Y, Harel EV, Braw Y, Sheer A, Zangen A (2007) A randomized controlled feasibility and safety study of deep transcranial magnetic stimulation. Clin Neurophysiol 118:2730–2744PubMedCrossRef

12.

Gersner R, Kravetz E, Feil J, Pell G, Zangen A (2011) Long-term effects of repetitive transcranial magnetic stimulation on markers for neuroplasticity: differential outcomes in anesthetized and awake animals. J Neurosci 31:7521–7526PubMedCrossRef

13.

Feng SF, Shi TY (2012) Fan-Yang, Wang WN, Chen YC, Tan QR. Long-lasting effects of chronic rTMS to treat chronic rodent model of depression. Behav Brain Res 232:245–251PubMedCrossRef

14.

Bentwich J, Dobronevsky E, Aichenbaum S et al (2011) Beneficial effect of repetitive transcranial magnetic stimulation combined with cognitive training for the treatment of Alzheimer’s disease: a proof of concept study. J Neural Transm 118(3):463–471PubMedCrossRef

15.

Cotelli M, Calabria M, Manenti R et al (2011) Improved language performance in Alzheimer disease following brain stimulation. J Neurol Neurosurg Psychiatry 82:794–797PubMedCrossRef

16.

Bates JF, Goldman-Rakic PS (1993) Prefrontal connections of medial motor areas in the rhesus monkey. J Comp Neurol 336:211–228PubMedCrossRef

17.

Selemon LD, Goldman-Rakic PS (1985) Longitudinal topography and interdigitation of corticostriatal projections in the rhesus monkey. J Neurosci 5:776–794PubMed

18.

Moser DJ, Jorge RE, Manes F et al (2002) Improved executive functioning following repetitive transcranial magnetic stimulation. Neurology 58:1288–1290PubMedCrossRef

19.

Lomarev MP, Kanchana S, Bara-Jimenez W et al (2006) Placebo-controlled study of rTMS for the treatment of Parkinson’s disease. Mov Disord 21:325–331PubMedCrossRef

20.

Strafella AP, Paus T, Barrett J et al (2001) Repetitive transcranial magnetic stimulation of the human prefrontal cortex induces dopamine release in the caudate nucleus. J Neurosci 21:1–4

21.

Knoch D, Treyer V, Regard M, Müri RM, Buck A, Weber B (2006) Lateralized and frequency-dependent effects of prefrontal rTMS on regional cerebral blood flow. Neuroimage 31:641–648PubMedCrossRef

22.

Goetz CG, Leurgans S, Raman R et al (2000) Objective changes in motor function during placebo treatment in PD. Neurology 54:710–714PubMedCrossRef

23.

Stamelou M, Reuss A, Pilatus U et al (2008) Short-term effects of coenzyme Q10 in progressive supranuclear palsy: a randomized, placebo-controlled trial. Mov Disord 23:942–949PubMedCrossRef

24.

Whitwell JL, Xu J, Mandrekar JN et al (2012) Rates of brain atrophy and clinical decline over 6 and 12-month intervals in PSP: determining sample size for treatment trials. Parkinsonism and Related Disorders 18:252–256PubMedCrossRef

25.

Trebbastoni A, Raccah R, de Lena C, Zangen A, Inghilleri M (2012) Repetitive deep transcranial magnetic stimulation improves verbal fluency and written language in a patient with primary progressive aphasia-logopenic variant (LPPA). Brain Stimul. pii:S1935-861X(12)00189–1

Title: Deep magnetic stimulation in a progressive supranuclear palsy patient with speech involvement
Authors: Francesca Spagnolo
Elisabetta Coppi
Pasquale Anthony Della Rosa
Mario Fichera
Alessandra Barbieri
Giuseppe Magnani
Monica Falautano
Abraham Zangen
Giancarlo Comi
Daniela Perani
Maria Antonietta Volontè
Letizia Leocani
Publication date: 01-02-2013
Publisher: Springer-Verlag
Published in: Journal of Neurology / Issue 2/2013
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-012-6772-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Deep magnetic stimulation in a progressive supranuclear palsy patient with speech involvement

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 2/2013

Neurosarcoidosis in a patient treated with tumor necrosis factor alpha inhibitors

Parkinson’s disease-like midbrain hyperechogenicity is frequent in amyotrophic lateral sclerosis

Treatment deviating from guidelines does not influence status epilepticus prognosis

Fourth nerve palsy presenting with trochleodynia

A randomized clinical trial of lithium in multiple system atrophy

Amyotrophic lateral sclerosis in Sardinia, insular Italy, 1995–2009